Search Results 261-270 of 24224 for depression
... depression. This better understanding of therapy impact on brain function may help individualize future treatment for bipolar depression. Participation ...
Depression. Anxiety disorders. Obsessive-compulsive disorder (OCD). Attention-deficit/hyperactivity disorder (ADHD). Prevention. Because little is understood ...
The purpose of this study is to determine the baseline chronotype patterns (with Morningness-Eveningness Questionnaire (MEQ) ) among inpatients with Major ...
This feasibility study aims to better understand the neurobiology of major depression and how ketamine may therapeutically impact brain function. This ...
... depression — the leading cause of medical disability worldwide. The system works by identifying patterns within patient history and other relevant data to ...
Pioneering therapeutic trials to investigate the effectiveness of deep brain stimulation (DBS) in hard-to-treat depression, obsessive-compulsive disorder ...
Adjunctive Lithium for Patients Receiving Clinical Intravenous Ketamine for Treatment Resistant Depression (TRD) · Overview · Participation eligibility.
Dosing · For depression: Adults—At first, 75 milligrams (mg) per day. Your doctor may adjust your dose as needed. · For enuresis (bedwetting):. Children 6 years ...
Dosing · For depression: Adults—At first, 75 milligrams (mg) per day, taken as one dose in the morning or evening. · For generalized anxiety disorder: Adults—At ...
The FLAME Study is a 16-week clinical trial to study treatment with lamotrigine or fluoxetine in bipolar I, II and bipolar schizoaffective depressed adults.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can go twice as far to fight cancer.